Tab Application Banner
  • Users Online: 680
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others


Development of the myocite biobank: Cost-efficient model of public sector investigator-driven biobank for idiopathic inflammatory myositis

Naveen R, Anuja Anamika Kumari, Rai Mohit Kumar, Agarwal Vikas, Gupta Latika

Year : 2020| Volume: 15| Issue : 6 | Page no: 194-199

   This article has been cited by
1 High burden of infections in Indian patients with Idiopathic Inflammatory Myopathy: validation of observations from the MyoCite dataset
Rudrarpan Chatterjee,Pankti Mehta,Vikas Agarwal,Latika Gupta
Rheumatology. 2021;
[Pubmed]  [Google Scholar] [DOI]
2 Teleconsultation experience with the idiopathic inflammatory myopathies: a prospective observational cohort study during the COVID-19 pandemic
R. Naveen,T. G. Sundaram,Vikas Agarwal,Latika Gupta
Rheumatology International. 2021; 41(1): 67
[Pubmed]  [Google Scholar] [DOI]
3 Characteristics and outcomes of overlap myositis: a comparative multigroup cohort study in adults from the MyoCite cohort
R. Naveen,Upendra Rathore,Vikas Agarwal,Latika Gupta
Rheumatology International. 2021;
[Pubmed]  [Google Scholar] [DOI]
4 High early mortality in idiopathic inflammatory myopathies: results from the inception cohort at a tertiary care centre in northern India
Pankti Mehta,Vikas Agarwal,Latika Gupta
Rheumatology. 2021;
[Pubmed]  [Google Scholar] [DOI]
5 Serum fatty acid-binding protein 3 levels differentiate active from inactive myositis and correlate with response to therapy
Latika Gupta,Sanjukta Majumder,Amita Aggarwal,Ramnath Misra,Able Lawrence
Indian Journal of Rheumatology. 2020; 15(6): 187
[Pubmed]  [Google Scholar] [DOI]


Read this article